SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-08-029117
Filing Date
2008-05-01
Accepted
2008-05-01 17:00:31
Documents
2
Effectiveness Date
2008-05-01

Document Format Files

Seq Description Document Type Size
1 DEFA14A a08-13185_18k.htm DEFA14A 30667
2 EX-99.1 a08-13185_1ex99d1.htm EX-99.1 28559
  Complete submission text file 0001104659-08-029117.txt   60608
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26301 | Film No.: 08795462
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1